Size of drug companies needs larger through M&A

An industry analyst alleged that in one way or the other possibly through M&A the pharmaceutical company size should make larger than now to compete with the foreign multinational drug corporations and to upgrade its competitiveness on the global markets by putting more efforts to the promotion of its brands and differentiated strategies.

Mr. Lee Yoon-ho, the head of LG Economy Institute sp...